AAA
PFE icon

American Alpha Advisors’s Pfizer PFE Stock Holding History

American Alpha Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$530K Buy
21,991
+177
+0.8% +$4.63K 0.29% 59
2026
Q1 		$613K Buy
21,814
+668
+3% +$17.8K 0.33% 54
2025
Q4 		$527K Buy
21,146
+2,955
+16% +$74.5K 0.31% 55
2025
Q3 		$464K Sell
18,191
-791
-4% -$19.5K 0.32% 50
2025
Q2 		$460K Buy
18,982
+2,478
+15% +$57.8K 0.36% 45
2025
Q1 		$418K Buy
+16,504
New +$432K 0.35% 56

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

American Alpha Advisors's PFE Position: Q2 2026 in Review

American Alpha Advisors increased its Pfizer (PFE) stake by 0.81% in Q2 2026, buying an estimated $4.63K and bringing the position to 21,991 shares worth $530K. The position accounts for 0.29% of the portfolio, ranked #59.

American Alpha Advisors first reported a position in PFE in Q1 2025 and has held it in 6 quarters since. The position peaked at $613K in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • American Alpha Advisors held 21,991 shares of Pfizer worth $530K as of Q2 2026.
  • American Alpha Advisors bought 177 Pfizer shares in Q2 2026, an estimated $4.63K.
  • Pfizer made up 0.29% of American Alpha Advisors's portfolio in Q2 2026, its #59 holding.
  • American Alpha Advisors first reported a position in Pfizer in Q1 2025 and has held it in 6 quarters since.
  • American Alpha Advisors's Pfizer position peaked at $613K in Q1 2026.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on American Alpha Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.